<?xml version="1.0" encoding="UTF-8"?>
<p>
 <italic>β</italic>-Caryophyllene is reported to possess anticancer, analgesic [
 <xref rid="B34-molecules-26-00119" ref-type="bibr">34</xref>], anticonvulsant [
 <xref rid="B35-molecules-26-00119" ref-type="bibr">35</xref>], anti-inflammatory [
 <xref rid="B36-molecules-26-00119" ref-type="bibr">36</xref>], antioxidant, and antimicrobial activities [
 <xref rid="B37-molecules-26-00119" ref-type="bibr">37</xref>], and its abundance, especially in the E, EQ, and ESEG varieties, makes them a possible source of this compounds. As a result, 
 <italic>β</italic>-caryophyllene was described as a potential agent to treat several diseases due to its activity [
 <xref rid="B38-molecules-26-00119" ref-type="bibr">38</xref>]. In addition, globulol, which was the highest compound in the RI variety, is reported to have various biological activities, such as antifungal [
 <xref rid="B39-molecules-26-00119" ref-type="bibr">39</xref>] and antibacterial activities [
 <xref rid="B40-molecules-26-00119" ref-type="bibr">40</xref>]. RI is also abundant in nerolidol and reported to possess antileishmanial [
 <xref rid="B41-molecules-26-00119" ref-type="bibr">41</xref>], antiparasitic [
 <xref rid="B42-molecules-26-00119" ref-type="bibr">42</xref>], antimalarial [
 <xref rid="B43-molecules-26-00119" ref-type="bibr">43</xref>], and antimicrobial activities [
 <xref rid="B44-molecules-26-00119" ref-type="bibr">44</xref>]. 
</p>
